Financials in USD. Standardized financial statements.
A compact view of how Definitive Healthcare Corp. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Revenue? | $241.52M | $252.20M | $251.41M | $222.65M | $166.15M | $118.32M | $85.50M |
| Revenue Growth? | -4.2% | +0.3% | +12.9% | +34.0% | +40.4% | +38.4% | 0.0% |
| Cost of Revenue? | $58.25M | $54.73M | $47.48M | $42.63M | $40.69M | $30.47M | $43.04M |
| Gross Profit? | $183.28M | $197.47M | $203.93M | $180.03M | $125.47M | $87.85M | $42.47M |
| Gross Margin? | +75.9% | +78.3% | +81.1% | +80.9% | +75.5% | +74.2% | +49.7% |
| Operating Expenses? | $203.86M | $908.29M | $533.73M | $224.07M | $152.78M | $103.73M | $44.64M |
| Operating Income? | -$20.58M | -$710.82M | -$329.80M | -$44.04M | -$27.32M | -$15.89M | -$2.17M |
| EBITDA? | -$162.15M | -$567.24M | -$241.23M | $26.23M | $23.08M | $43.47M | $15.51M |
| Income Before Tax | -$209.26M | -$633.75M | -$308.18M | -$41.88M | -$62.77M | -$52.60M | -$36.40M |
| Income Tax Expense | -$9.96M | -$42.30M | -$18.55M | -$17.70M | -$443,000 | $0 | $0 |
| Net Income? | -$138.93M | -$413.12M | -$202.39M | -$7.22M | -$51.91M | -$52.60M | -$36.40M |
| EPS? | $-1.30 | $-3.54 | $-1.79 | $-0.07 | $-0.19 | $-0.53 | $-0.24 |
| Diluted EPS? | $-1.30 | $-3.54 | $-1.79 | $-0.07 | $-0.19 | $-0.53 | $-0.24 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality